Do you want to read an article? Please log in or register.
Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases
Glaucoma and Ocular PressureMacular DiseasesOcular OncologyRetinal Diseases
Related content
Dry Eye Disease
Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review
Ocul Surf.
Holland EJ, Darvish M, Nichol KK,
Jones L, Karpecki PM
doi: 10.1016/j.jtos.2019.02.012.
Blindness and Vision ImpairmentFurther Publications
A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews
JAMA Ophthalmol
Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, Ehrlich JR, Swenor BK
doi: 10.1001/jamaophthalmol.2021.0146
A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease
Ophthalmology.
Deinema LA, Vingrys AJ, Wong CY, Jackson DC, Chinnery HR, Downie LE
doi: 10.1016/
Macular Diseases
Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
Health Technol Assess.
Waugh N, Loveman E, Colquitt J, Royle P, Yeong JL, Hoad G,
Lois N
doi: 10.3310/hta22270.
COMMENTED
Macular Diseases
Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial
★ 2
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2020.0437.
Macular Diseases
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19
Ophthalmol Retina.
Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY, Age-Related Eye Disease Study 2 Research Group.
doi: 10.1016/j.oret.2019.06.001.
COMMENTED
Blindness and Vision Impairment
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
BMJ
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM
doi: 10.1136/bmj.m4573
Further PublicationsDry Eye Disease
Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials
JAMA Ophthalmol
Holland EJ, Jackson MA, Donnenfeld E, Piccolo R, Cohen A, Barabino S, Rolando M, Figueiredo FC
doi: 10.1001/jamaophthalmol.2021.3943
Retinal Diseases
Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials
Prog Retin Eye Res
Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, Fleckenstein M, Holz FG, Schmitz-Valckenberg S
doi: 10.1016/j.preteyeres.2020.100907